An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Simon Berritt Heather Eng Alyssa Dantonio Dafydd R. Owen |
| Publication date | December 24, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |